XCell Science Competitors and Similar CompaniesClear all
XCell Science's competitors and similar companies include Hopstem Biotechnology, Arrowhead Pharmaceuticals, Wave Life Sciences and Vivet Therapeutics.
 XCell Science XCell Science is a biotechnology company specialized in the production of neural cells from human pluripotent stem cells (PSCs). |  Hopstem Biotechnology Hopstem Biotechnology (霍德生物) is a company committed to producing neural stem cell products for CNS drug screening and toxicity evaluation, as well as clinical cell therapy and regeneration medicine. |  Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals is a biopharmaceutical company that specializes in drug development. |  Wave Life Sciences Wave Life Sciences is a clinical stage genetic medicine company focused on advancing stereo pure nucleic acid therapeutics that precisely target the underlying cause of rare diseases, with a goal of delivering exceptional treatment options for patients. |  Vivet Therapeutics Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. | |
Founding Date | Founding Date 2010 | Founding Date 2017 | Founding Date 2001 | Founding Date 2012 | Founding Date 2016 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Novato, US HQ Novato, US Novato, US | Locations Hangzhou Shi, CN HQ Houston, US | Locations Pasadena, US HQ Madison, US San Diego, US | Locations Cambridge, US HQ Dublin 1, IE Kagoshima, JP Singapore, SG Birmingham, GB Lexington, US | Locations Paris, FR HQ |
Employees | Employees 2 | Employees 614% decrease | Employees 13416% increase | Employees 23522% decrease | Employees 195% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.5 b | Valuation ($) 2.3 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $829.4m (FY, 2025) | Revenue (est.) $42.7m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income N/A | Net income $30.1m (FY, 2025) | Net income ($204.4m) (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Patents Issued | Patents Issued N/A | Patents Issued N/A | Patents Issued 359 (FY, 2016) | Patents Issued 27 (FY, 2016) | Patents Issued N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 1.7m (almost 9 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 51.2m (about 7 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 1.7m | Total funding raised $ 147.1m | Total funding raised $ 30m | Total funding raised $ 92.1m |
For sources of this data, please see the company profile
View Company Profiles
Hopstem Biotechnology
HQ
Hangzhou Shi, CN
Employees
6↓ 14% decrease
Hopstem Biotechnology (霍德生物) is a company committed to producing neural stem cell products for CNS drug screening and toxicity evaluation, as well as clinical cell therapy and regeneration medicine.
View companyArrowhead Pharmaceuticals
HQ
Pasadena, US
Employees
134↑ 16% increase
Arrowhead Pharmaceuticals is a biopharmaceutical company that specializes in drug development.
View companyWave Life Sciences
HQ
Cambridge, US
Employees
235↓ 22% decrease
Wave Life Sciences is a clinical stage genetic medicine company focused on advancing stereo pure nucleic acid therapeutics that precisely target the underlying cause of rare diseases, with a goal of delivering exceptional treatment options for patients.
View companyVivet Therapeutics
HQ
Paris, FR
Employees
19↓ 5% decrease
Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases.
View company